Rose Medical Center is a part of HCA Healthcare's HealthONE network. Located in Denver, Colorado, Rose has been well known as a Denver institution and a 9th Avenue landmark since its founding.

There are 422 beds in Rose Medical Center.

During the past decade, Rose Medical Center conducted 103 clinical trials. In the 10-year time frame, 103 clinical trials started and 158 clinical trials were completed, i.e. on average, 153.4% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 68 clinical trials were completed. i.e. 206.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rose Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 112 trials, followed by "Alliance for Clinical Trials in Oncology" with 65 trials sponsored, "SWOG Cancer Research Network" with 34 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored and "Eastern Cooperative Oncology Group" with 19 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rose Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 162 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator and "NCIC Clinical Trials Group" with 10 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Rose Medical Center" are "Breast Cancer" (24 trials), "Lymphoma" (13 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials), "Lung Cancer" (11 trials) and "Recurrent Breast Carcinoma" (10 trials). Many other conditions were trialed in "Rose Medical Center" in a lesser frequency.

Most popular intervention types in "Rose Medical Center" are "Drug" (234 trials), "Other" (162 trials), "Biological" (129 trials), "Procedure" (53 trials) and "Radiation" (28 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (78 trials), "Quality-of-Life Assessment" (50 trials), "Paclitaxel" (31 trials), "placebo" (29 trials) and "Questionnaire Administration" (25 trials). Other intervention names were less common.

The vast majority of trials in "Rose Medical Center" are 234 trials for "All" genders, 53 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Rose Medical Center". undefined are not yet recruiting, 33 are recruiting, 101 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 124 completed trials in Rose Medical Center, 4 suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Rose Medical Center, 5 "Phase 1" clinical trials were conducted, 123 "Phase 2" clinical trials and 155 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".